Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 6, 2002, Pages 1372-1375

  Monsalve de Castillo, Francisca ^a   Romero, Tania A ^a   Estévez, Jesús ^a   Costa, Luciana L ^a   Atencio, Ricardo ^a   Porto, Leticia ^a   Callejas, Diana ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD30 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONVALESCENCE; HEPATITIS B; HUMAN; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; VIRUS REPLICATION;

ADULT; ANTIGENS, CD30; CYTOKINES; HEPATITIS B; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036844293     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.6.1372-1375.2002     Document Type: Article

References (36)

1. Alberti, N., and F. Colina. 1995. Histologia de la hepatitis B: Avance en la interpretación diagnóstica y patogénica. Hepat. Clin. 2:73-82.
2. Al-Wabel, A., M. Al-Janadi, and S. Raziuddin. 1993. Cytokine profile of viral and auto immune chronic active hepatitis. J. Allergy Clin. Immunol. 92:902-908.
3. Anastassakos, A., A. Wolstencroft, P. Portman, E. De Dumon, and W. Roge. 1998. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 94:999-1005.
4. Andus, T., J. Bauer, and W. Gerok. 1991. Effects of cytokines on the liver. Hepatology 13:364-375.
5. Biron, C. A. 1994. Cytokines in the generation of immune response to, and resolution of virus infection. Curr. Opin. Immunol. 6:530-538.
6. Bocher, W. O., E. Galun, H. Marcus, N. Daudi, D. Terkieltaub, D. Shouval, H. F. Lhor, and Y. Reisner. 2000. Reduced hepatitis B virus surface antigen-specific Thl helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trinera mouse. Hepatology 31:480-487.
7. Borish, L. 1998. Updates on cell and cytokine. J. Allergy Clin. Immunol. 101:293-297.
8. Chisari, F. V. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
9. Chu, C. M., I. S. Sheen, C. Y. Yeh, S. Y. Hsieh, S. L. Tsai, and Y. F. Liaw. 1995. Serum levels of interferon-alpha and gamma in acute and chronic hepatitis B virus infection. Dig. Dis. Sci. 40:2107-2112.
10. + T cells producing Th2-type cytokines. FASEB J. 9:81-86.
11. Diamantstein, T., H. Osawa, A. Mouzaki, and A. O. Josimovic. 1986. Regulation of interleukin-2 receptor expression and receptor release. Mol. Immunol. 23:1165-1172.
12. Echevarría, J. M., and P. Leon. 1995. Hepatitis B virus: Biology, natural history, and diagnosis of the infection. Enferm. Infecc. Microbiol. Clin. 13:22-30.
13. Echevarría, J. M., L D. Blitz, and F. Pujol. 1996. La infección por los virus causantes de hepatitis en poblaciones indígenas de suramérica: Una revisión del problema. Investig. Clin. 37:191-200.
14. Echevarría, S., F. Casafont, J. L. Miera, F. De La Cruz, G. San Miguel, and F. P. Romero. 1991. Interleukin-2 and natural killer activity in acute type B hepatitis. Hepatogastroenterology 4:307-310.
15. Engvall, E., and P. Perlmann. 1971. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871-874.
16. Engvall, E., and P. Perlmann. 1971. Enzyme-linked immunosorbent assay (ELISA). Protides of the biological fluids, p. 553-556. In H. Peeters (ed.), Proceedings of the Nineteenth Colloquium. Pergamon Press, Oxford, United Kingdom.
17. Falini, B., S. Pileri, G. Pizzolo, H. Durkip, L. Flenghi, F. Stirpe, F. M. Martelli, and H. Stein. 1995. CD30 (ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1:1-14.
18. Fattovich, G., F. Vinante, G. Giuestina, L. Morosato, A. Alberti, and G. Pizzolo. 1996. Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin. Exp. Immunol. 103:105-110.
19. Fujinami, R. S., and M. A. Oldstone. 1979. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 279:529-530.
20. Gilles, P., G. Fey, and F. V. Chisari. 1992. Tumor necrosis factor alpha negatively regulates hepatitis b virus gene expression in transgenic mice. J. Virol. 66:3955-3960.
21. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V . Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1:25-36.
22. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expression of distinct helper T cell subset. J. Exp. Med. 169:59-72.
23. Izzo, F., S. Curley, P. Maio, E. Leonardi, L. Imparato, S. Giglio, F. Cremona, and G. Castello. 1996. Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancer. Surgery 1:100-105.
24. Joklik, W. K. 1991. Interferons, p. 343-361. In B. N. Fields, D. M. Knipe, et al. (ed.), Fundamental Virology, 2nd Ed. Raven Press, New York, N.Y.
25. Juszczyk, J. 2000. Clinical course and consequences of hepatitis B infection. Vaccine 2000 1:S23-S25.
26. Kelso, A. 1995. Th1 and Th2 subsets: Paradigms lost? Immunol. Today 8:374-379.
27. Lee, M., M. Lee, S. K. Lee, M. Son, S. W. Sho, S. Park, and H. I. Kim. 1999. Expression of Th1 and Th2 type cytokines responding to HbsAg and HbxAg in chronic hepatitis B patients. J. Korean Med. Sci. 2:175-181.
28. Lohr, H. F., J. F. Schlaak, G. Gerken, B. Fleischer, H. P. Dienes, and Z. B. Meyer. 1994. Phenotypical analysis and cytokine release of liver infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 3:161-166.
29. Machado, B. I., L. Deibis, and F. Toro. 1997. Respuesta inmunológica en hepatitis viral. Gen. 2:85-93.
30. Mansour, A. J., A. W. Abdulhamid, and R. Syed. 1994. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1:33-37.
31. Missale, G., C. Ferrari, and F. Fiaccadori. 1995. Cytokines mediators in acute inflammation and chronic course of viral hepatitis. Ann. Ital. Med. Int. 1:14-18.
32. Penna, A., G. Del Prete, A. Cavalli, A. Bertoleti, M. D'elios, and R. Sarmiento. 1997. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cell in acute self-limited hepatitis B. Hepatitis 4:1022-1027.
33. Raynor, B. D. 1996. Cytokines. Adv. Obstet. Gynecol. 3:27-46.
34. Tilg, H., A. Wilmer, W. Vogel, M. Herold, B. Nolchen, G. Julmaier, and C. Huber. 1992. Serum levels of cytokines in chronic liver disease. Gastroenterology 103:264-274.
35. Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFNg). Curr. Opin. Immunol. 9:17-23.
36. Vetencourt, R., and M. Vetencour. 1997. Epidemiologia de las hepatitis virales en Venezuela. Gastroenterol. Endocrinol. Nutr. 2:135-140.